These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 15572272

  • 1. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia.
    Janno S, Holi MM, Tuisku K, Wahlbeck K.
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):39-41. PubMed ID: 15572272
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study.
    Baskak B, Atbasoglu EC, Ozguven HD, Saka MC, Gogus AK.
    J Clin Psychopharmacol; 2007 Jun; 27(3):289-94. PubMed ID: 17502777
    [Abstract] [Full Text] [Related]

  • 5. [Subjective experiences of patients with acute neuroleptic-induced akathisia].
    Gruber O, Northoff G, Pflug B.
    Fortschr Neurol Psychiatr; 1998 Dec; 66(12):531-8. PubMed ID: 9922925
    [Abstract] [Full Text] [Related]

  • 6. Neuroleptic-induced acute and chronic akathisia: a clinical comparison.
    Kim JH, Jin YH, Kang UG, Ahn YM, Ha KS, Kim YS.
    Mov Disord; 2005 Dec; 20(12):1667-70. PubMed ID: 16078203
    [Abstract] [Full Text] [Related]

  • 7. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN, Shelton MD, Baker RW, Schooler NR, Baird J, Delaney J.
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Beta 2-receptor density on mononuclear blood cells in patients suffering from neuroleptic-induced akathisia (NIA).
    Botschev C, Bondy B, Hofmann M, Kircher T, Müller-Spahn F.
    Biol Psychiatry; 1996 Aug 01; 40(3):203-7. PubMed ID: 8830953
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
    Sivrioglu EY, Kirli S, Sipahioglu D, Gursoy B, Sarandöl E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1493-9. PubMed ID: 17688987
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia.
    Poyurovsky M, Bergman J, Pashinian A, Weizman A.
    Int Clin Psychopharmacol; 2014 Sep 01; 29(5):296-8. PubMed ID: 24667488
    [Abstract] [Full Text] [Related]

  • 18. Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia.
    Maat A, Fouwels A, de Haan L.
    Psychopharmacol Bull; 2008 Sep 01; 41(3):5-10. PubMed ID: 18779773
    [Abstract] [Full Text] [Related]

  • 19. Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia.
    Poyurovsky M, Nave R, Epstein R, Tzischinsky O, Schneidman M, Barnes TR, Weizman A, Lavie P.
    Eur Neuropsychopharmacol; 2000 May 01; 10(3):171-6. PubMed ID: 10793319
    [Abstract] [Full Text] [Related]

  • 20. Case study of neuroleptic-induced akathisia: important implications for individuals with mental retardation.
    Gross EJ, Hull HG, Lytton GJ, Hill JA, Piersel WC.
    Am J Ment Retard; 1993 Jul 01; 98(1):156-64. PubMed ID: 8103997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.